Rejoni, a clinical-stage women’s health company focused on biomaterial therapies, announced the closing of a $25 million financing round to support the development and commercialization of the Juveena Hydrogel System.
The financing included participation from new and existing investors, including Clavyst Bio, Amed Ventures, Ascension Ventures, Catalyst Health Ventures, Delos Capital, FemHealth Ventures, Iyengar Capital, and Sparta Group.
Based in Bedford, Massachusetts, Rejoni is focused on improving uterine health through innovative biomaterials. The company plans to use the proceeds to prepare for the commercial launch of Juveena, scale manufacturing and supply operations, invest in market access initiatives, and expand physician and patient engagement efforts ahead of potential U.S. Food and Drug Administration approval.
Juveena is designed to support endometrial healing following intrauterine surgery, which is a leading cause of intrauterine adhesions. The investigational system uses a proprietary transcervical catheter to place a temporary hydrogel spacer inside the uterine cavity during the healing process, with the goal of reducing the incidence and severity of adhesions.
Rejoni was founded in June 2020 by serial entrepreneur Amar Sawhney, who previously founded Confluent Surgical, Ocular Therapeutix, and Augmenix. The company is led by CEO John Nealon and is advancing its first product as it moves toward regulatory approval and commercialization.
KEY QUOTES:
“Uterine health has been underserved for too long, and this financing puts us in a position to change that. We are building the infrastructure, commercial readiness, market access, and physician engagement to ensure we can move quickly when Juveena is approved.”
John Nealon, Chief Executive Officer of Rejoni
“This financing marks an important milestone in Rejoni’s evolution from building the science to preparing for launch. John and the team have the experience and drive to execute on this opportunity, and I remain fully committed to this mission.”
Amar Sawhney, Founder and Chairman of Rejoni
